SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053574
Filing Date
2020-11-12
Accepted
2020-11-12 16:16:29
Documents
71
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q atha-10q_20200930.htm 10-Q 2947651
2 EX-3.1 atha-ex31_153.htm EX-3.1 38821
3 EX-3.2 atha-ex32_154.htm EX-3.2 275368
4 EX-31.1 atha-ex311_6.htm EX-31.1 16012
5 EX-31.2 atha-ex312_7.htm EX-31.2 16143
6 EX-32.1 atha-ex321_8.htm EX-32.1 9334
7 EX-32.2 atha-ex322_9.htm EX-32.2 9123
  Complete submission text file 0001564590-20-053574.txt   8845266

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT atha-20200930.xml EX-101.INS 1632938
9 XBRL TAXONOMY EXTENSION SCHEMA atha-20200930.xsd EX-101.SCH 61178
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atha-20200930_cal.xml EX-101.CAL 48582
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atha-20200930_def.xml EX-101.DEF 192514
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE atha-20200930_lab.xml EX-101.LAB 476261
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atha-20200930_pre.xml EX-101.PRE 358508
Mailing Address 4000 MASON ROAD, SUITE 300 BOX 352141 SEATTLE WA 981952141
Business Address 4000 MASON ROAD, SUITE 300 BOX 352141 SEATTLE WA 981952141 5095927191
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39503 | Film No.: 201306906
SIC: 2836 Biological Products, (No Diagnostic Substances)